🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these accounts directly for source information, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, injection guides and claims of next-day UK delivery. Vendors market the drug there before directing buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could result in individuals administering products of unknown origin.

Several experts stated the demand for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Reaction and Material Removal

Based on the social media company, the service has taken down problematic material and prohibited related keywords and query recommendations. The company stated it was committed to keeping the platform secure and investing in enhancing compliance measures.

Online Trading Activities

Research also discovered groups with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, glowing testimonials and step-by-step instructions for preparing or administering at residence.

Within moments of entering one community, a seller shared contact information, where most transactions occur. The seller sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Product Details and Costs

Inside these groups, posts show black plastic packages with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with sterile water, or pre-filled pens usually priced at 160 pounds for 20mg. When questioned how much time a injector should be used, sellers give contradictory responses varying between a several days to “depends on your body”.

Service Moderation and Safety Measures

A representative for the messaging service said it actively moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting materials they can’t verify. Even if the research behind this drug is sound, these online products may not contain what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has already seen patients injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to possibly significant health risks”.